Why Part D can't cover weight loss on its own
Federal law (Social Security Act §1860D-2(e)) excludes drugs used for weight loss from Part D. That's why a Nevada Part D plan, or a Medicare Advantage plan with drug coverage, can't put Wegovy or Zepbound on its formulary just for weight management. It can cover them for other medically accepted uses on their FDA labels. A separate CMS program, the Medicare GLP-1 Bridge, covers weight management for some people through 2027.
This page explains Medicare coverage only. Questions about whether either drug is right for you belong with your prescriber.
What a Part D plan can cover them for
| Drug | FDA-labeled uses a Part D plan can cover | Weight management alone |
|---|---|---|
| Wegovy injection (semaglutide) | Lowering the risk of cardiovascular death, heart attack or stroke in adults with established heart disease and obesity or overweight; MASH (a fatty liver disease) with moderate to advanced liver scarring in adults | Not by your plan; the GLP-1 Bridge if eligible |
| Wegovy tablets (semaglutide) | Lowering the risk of cardiovascular death, heart attack or stroke in adults with established heart disease and obesity or overweight | Not by your plan; the GLP-1 Bridge if eligible |
| Zepbound (tirzepatide) | Moderate to severe obstructive sleep apnea in adults with obesity | Not by your plan; the GLP-1 Bridge (KwikPen only) if eligible |
A plan doesn't have to list either drug, and plans that do usually require prior authorization so your prescriber can show the use isn't weight loss alone. Wegovy's MASH use has accelerated approval, which the label says may depend on a confirmatory trial.
How the Medicare GLP-1 Bridge works
- Dates: July 1, 2026, through December 31, 2027. CMS hasn't announced coverage after that.
- Drugs: Wegovy (injection or tablet), the Zepbound KwikPen and Foundayo (a tablet). Medicare.gov says the Bridge doesn't cover single-dose Zepbound vials or pens.
- Who qualifies: people 18 or older with Part D drug coverage (a standalone plan or a Medicare Advantage plan with drug coverage) who, when starting the drug, have a BMI of 35 or more; or 30 or more with diastolic heart failure, uncontrolled high blood pressure or chronic kidney disease stage 3a or higher; or 27 or more with prediabetes, a past heart attack or stroke, or peripheral artery disease with symptoms.
- Who doesn't: people who already get a GLP-1 through their Part D plan, and people with type 2 diabetes, moderate to severe sleep apnea or fatty liver disease. For those conditions, your Part D plan might cover a GLP-1 instead.
- How: your prescriber sends the prescription to the pharmacy and, when asked, completes a prior authorization certifying you're using the drug with a diet and exercise program. You get a letter in the mail confirming coverage, and the approval lasts through December 31, 2027, unless you change GLP-1s.
- Cost: a flat copay for each one-month supply, set by CMS and shown on Medicare.gov. It runs outside your plan: the Part D deductible doesn't apply, no part of the Bridge copay counts toward the $2,400 cap, and Extra Help doesn't lower it.
Check eligibility at Medicare.gov/glp1bridge or call 1-800-MEDICARE (1-800-633-4227, TTY 1-877-486-2048).
Do Wegovy or Zepbound have Medicare negotiated prices?
Wegovy: yes, from 2027. CMS selected semaglutide, which it lists as Ozempic, Rybelsus and Wegovy, in the second round of the Medicare Drug Price Negotiation Program, with a negotiated price starting January 1, 2027. Zepbound: no. Tirzepatide (Zepbound and Mounjaro) isn't among the drugs selected for 2026, 2027 or 2028. A negotiated price is what plans and pharmacies pay when a plan covers the drug; it doesn't let a plan cover weight loss.
What you pay for Wegovy or Zepbound in 2027: the out-of-pocket cap
What you pay for Wegovy or Zepbound depends on your plan: its deductible, where it places the drug on its drug list, and whether you use a preferred pharmacy. This site doesn't list plan costs; your plan's formulary and Evidence of Coverage do. What Medicare sets for everyone with Part D is the limit:
- 2027 out-of-pocket cap: $2,400 (it was $2,100 in 2026). Once what you pay for covered Part D drugs (deductible, copays and coinsurance) reaches the cap, you pay nothing more for covered Part D drugs for the rest of 2027.
- The maximum Part D deductible for 2027 is $700. No plan can set a higher deductible.
- Only covered drugs count. If your plan doesn't cover Wegovy or Zepbound and you pay cash, or you use a discount card instead of your plan, that spending doesn't count toward the cap.
Spreading the cost: the Medicare Prescription Payment Plan
Anyone with a Medicare drug plan, or a Medicare Advantage plan with drug coverage, can use the Medicare Prescription Payment Plan. Instead of paying the pharmacy at the counter, you get a monthly bill from your plan that spreads your out-of-pocket costs for covered drugs across the calendar year. Medicare.gov says there's no cost to participate, but it doesn't save you money or lower your drug costs; it only changes when you pay. It helps most when a costly drug would otherwise mean a large bill early in the year. To join, call your plan or use its website.
Extra Help and Medicare Savings Programs in Nevada
Extra Help (the Low-Income Subsidy) is a federal program that lowers Part D premiums, deductibles and copays. For 2027, CMS caps Extra Help copays for covered drugs at $5.80 for a generic and $14.40 for a brand-name drug, and some people with full Medicaid pay less. You get Extra Help automatically if you have full Nevada Medicaid, SSI or a Medicare Savings Program (QMB, SLMB or QI). Otherwise, apply through Social Security at ssa.gov/extrahelp or 1-800-772-1213 (TTY 1-800-325-0778).
Nevada's Medicare Savings Programs, which can pay your Part B premium, are run by the Division of Social Services (DSS). You apply through Access Nevada or by calling DSS at (800) 992-0900. When you apply for Extra Help, Social Security sends your information to the state, and Nevada's DSS manual says DSS must treat it as an application for QMB, SLMB or QI. See Extra Help in Nevada and Medicare Savings Programs in Nevada.
Getting Wegovy or Zepbound covered in Nevada
Nevada is its own Part D region (CMS PDP Region 29), so each standalone Part D plan sold here is offered in all 17 counties. For 2027, CMS lists 9 standalone Part D plans from 5 companies in Nevada. Medicare Advantage choices depend on your county, and Clark County has the most. In Elko, Esmeralda, Eureka, Humboldt, Lander, Lincoln, Pershing and White Pine counties, CMS's 2027 plan list has no regular Medicare Advantage plan open to everyone, so a standalone Part D plan is the way to get Medicare drug coverage there unless you qualify for a special needs plan. Each plan has its own formulary, so one plan's coverage of Wegovy or Zepbound tells you nothing about another's. Your county's numbers are on Nevada counties.
- Full Nevada Medicaid and Medicare: your prescriptions are paid by your Medicare drug coverage, not by Nevada Medicaid, and Extra Help is automatic. See Nevada Medicaid and Medicare.
- No state drug program: Nevada's Senior Rx and Disability Rx program ended on December 31, 2023. Extra Help is now the main public help with Part D costs.
- Las Vegas heat: Wegovy's FDA label says to keep single-dose pens and syringes in the refrigerator at 36°F to 46°F; if needed, before the cap comes off, they can be kept at 46°F to 86°F for up to 28 days. A Wegovy FlexTouch pen can be kept at 59°F to 86°F or in the refrigerator for 56 days after first use; Wegovy tablets should be kept dry. Zepbound's label says to refrigerate it at 36°F to 46°F; a single-dose pen or vial can be unrefrigerated, at no more than 86°F, for up to 21 days, and a KwikPen kept at room temperature (up to 86°F) must be thrown away after 30 days. Neither may be frozen. The National Weather Service's normal daily high in Las Vegas in July is 103°F to 105°F, and even the normal overnight low (80°F to 83°F) is close to the 86°F ceiling on these labels. Don't leave Wegovy or Zepbound in a car, a mailbox or on a doorstep. If you use mail order, ask the pharmacy how it ships temperature-sensitive drugs in summer and when to expect the delivery. If a power outage or evacuation ruins your supply, call your plan about a replacement fill. See early refills during an evacuation and heat, wildfire and Medicare in Nevada.
- Rural Nevada and mail order: 14 of Nevada's 17 counties are rural or frontier, according to the University of Nevada, Reno's Rural and Frontier Health Data Book. Federal rules require each Part D plan's network in rural areas to put at least 70% of its members, on average, within 15 miles of a network retail pharmacy, and mail-order pharmacies can only add to that network (42 CFR 423.120). Ask a plan whether the pharmacy you use is in its network and whether it offers mail order. See rural Nevada and Medicare.
- If your Medicare Advantage plan ends in 2027: your plan sends a non-renewal letter, and you have a special enrollment period through February 28, 2027. To keep Wegovy or Zepbound covered without a gap, choose new drug coverage by December 31, 2026. See plans ending in 2027.
- State and university retirees (PEBP): if you're on Medicare and use the Medicare exchange PEBP arranges, your drug coverage comes from the individual plan you choose there, so check that plan's formulary. See PEBP retirees and Medicare.
How to check whether a plan covers Wegovy or Zepbound
- Write down the exact drug. Name, strength, form and how often you take it. A plan can cover one form or strength of Wegovy or Zepbound and not another.
- Look it up in each plan's formulary. Enter your drugs and ZIP code on PlanMatch or Medicare.gov's Plan Finder to see which plans list Wegovy or Zepbound and any rules.
- Read the rules next to the drug. Prior authorization, step therapy or quantity limits mean your prescriber may need to send the plan information before it pays.
- Check your 2027 notice. Your plan's Annual Notice of Change says whether Wegovy or Zepbound stays on the formulary next year. Open Enrollment runs October 15 to December 7, 2026, for coverage starting January 1, 2027.
- Get help if you want it. You can request a call from a licensed insurance agent, who can compare plans from the companies they work with, or call 1-800-MEDICARE (1-800-633-4227, TTY 1-877-486-2048).
If your plan doesn't cover Wegovy or Zepbound, you or your prescriber can ask for a coverage determination or a formulary exception. Once the plan has your prescriber's supporting statement, it generally must decide within 72 hours, or 24 hours if your prescriber says waiting could seriously harm your health. New members can usually get a one-time transition supply of a drug they were already taking while they ask. See How do I appeal a Medicare denial in Nevada? and Medicare appeals in Nevada.
Sources
- National Library of Medicine — DailyMed: Wegovy (semaglutide) injection and tablets prescribing information (FDA label)
- National Library of Medicine — DailyMed: Zepbound (tirzepatide) injection prescribing information (FDA label)
- Social Security Act §1860D-2(e) — drugs excluded from Part D (including drugs for weight loss)
- Medicare.gov — Weight loss drugs (Medicare GLP-1 Bridge)
- CMS — Medicare GLP-1 Bridge (July 1, 2026, to December 31, 2027)
- Medicare.gov — Drug coverage (Part D)
- CMS — Selected drugs and negotiated prices (2026 and 2027 lists and removals; updated November 2, 2026)
- CMS — CY 2027 Rate Announcement (2027 Part D cap, deductible and Extra Help copays)
- Medicare.gov — Medicare Prescription Payment Plan
- Social Security — Extra Help with Medicare prescription drug plan costs
- Nevada Division of Social Services — Medical Assistance Manual B-300 (Medicare Beneficiary programs, B-310; MTL 02/25)
- CMS — Medicare Advantage and Part D Landscape files, 2027 (PDP Region 29: Nevada)
- 42 CFR 423.120 — Part D pharmacy access standards (Legal Information Institute)
- University of Nevada, Reno School of Medicine — Nevada Rural and Frontier Health Data Book (2025)
- National Weather Service Las Vegas — July climate data for Las Vegas (1991–2020 normals)
Frequently asked questions
Will Medicare pay for Wegovy or Zepbound for weight loss in 2027?
Only through the Medicare GLP-1 Bridge, which runs through December 31, 2027, for eligible people with Part D coverage. Your Part D plan itself can't cover either drug for weight loss alone.
Can my Part D plan cover Zepbound for sleep apnea?
Yes, if Zepbound is on its formulary. Zepbound's FDA label includes moderate to severe obstructive sleep apnea in adults with obesity, which isn't a weight-loss use. Expect prior authorization.
I have type 2 diabetes. Can I use the GLP-1 Bridge?
No. Medicare.gov says people with type 2 diabetes aren't eligible, because a Part D plan may cover a diabetes GLP-1 such as Ozempic or Mounjaro instead.
Does the GLP-1 Bridge copay count toward the Part D cap?
No. CMS says no part of the Bridge copay counts toward your out-of-pocket costs, the Part D deductible doesn't apply, and Extra Help doesn't lower it.
Medicare in your Nevada county
Plans, local agents and help, county by county: Clark · Washoe · Lyon · Carson City · Nye · Elko · Douglas · Churchill · Humboldt · White Pine · Pershing · Lander · Mineral · Lincoln · Storey · Eureka · Esmeralda · All 17 counties →